Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Topic: Coronary

Monday, 25 April 2016

Ezetimibe (Ezetrol®), which is used to treat hypercholesterolaemia in combination with a statin, has been granted a new indication by the Medicines and Healthcare products Regulatory Agency (MHRA). The drug is now also indicated to reduce the risk of cardiovascular events in patients with coronary heart disease and a history of acute coronary syndrome when added to ongoing statin therapy or started with a statin.

Category: Have You Heard
Wednesday, 12 June 2019

This month’s double Back to Basics feature focuses on coronary artery disease and understanding the differences between stable angina, unstable angina, STEMI and NSTEMI, and their secondary prevention and management in primary care.

Category: Back to Basics
Wednesday, 12 June 2019

This month’s double Back to Basics feature focuses on coronary artery disease and understanding the differences between stable angina, unstable angina, STEMI and NSTEMI, and their secondary prevention and management in primary care.

Category: Back to Basics
Thursday, 27 March 2014

Most people with coronary heart disease (CHD) can be managed with lifestyle change and optimal medical therapy, but some patients need to be referred for revascularisation procedures such as angioplasty with stenting (also called percutaneous coronary intervention; PCI). Practice nurses have an important role to play in follow-up of these patients to minimise adverse events, promote lifestyle change and ensure continuing concordance with medication.

Category: Editorial
Monday, 28 February 2005

This article considers a possible scenario in primary care in which a patient presents with chest pain. Test yourself to see what you would do. Then check this against our recommendations, reflecting on your current procedures and policies within your practice.

Category: Editorial
Wednesday, 06 December 2017
Percutaneous coronary intervention (PCI) is not significantly better than a placebo procedure in improving exercise capacity or symptoms even in patients with severe coronary stenosis, according to new UK research. The ORBITA study is the first double blind randomised controlled trial to directly compare stenting with placebo in patients with stable angina who are receiving high quality drug treatment.
Friday, 30 June 2017

The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event. Don't miss out, last few places available

Category: Editorial
Wednesday, 20 May 2009

In this article, we look at how a primary prevention team introduced a systematic approach to target people who had premature coronary heart disease in their family and offer them a comprehensive cardiovascular disease risk assessment.Based on the findings from the EUROACTION study, the next step was to involve their partners based on the recognition that they often share risk factors due to lifestyle.

Category: Editorial
Monday, 21 March 2011

In the UK, the last 30 years have seen a significant decline in deaths from coronary heart disease (CHD) in men, but the fall has been less significant in women. This may be because women need a different, more gender-specific approach if they are to benefit fully from recent advances in treatment.

Category: Editorial
Page 1 of 2

Article search and filter